HIV Self-Testing Africa Zambia

NCT02793804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5005

Last updated 2018-05-14

No results posted yet for this study

Summary

This study consists of a Cluster Randomised Trial (CRT) of community and facility-based HIVST distribution by the Society for Family Health (SFH) in multiple rural and peri-urban settings. The study will take place in 6 matched pairs of health facilities and their catchment areas have been selected for study inclusion in collaboration with the district medical office (DMO). One clinic catchment area from each pair will be randomly allocated to the HIVST arm (intervention) and the other to the standard of care (SOC) arm (Control).In the HIVST arm, community-based distribution agents (CBDA), including Voluntary Medical Male Circumcision (VMMC) mobilisers, will deliver HIVST kits. The kits will also be available at the health facility. In the SOC arm, all HIV testing and counseling (HTC) services will be conducted as currently.

Conditions

Interventions

DEVICE

Oraquick (made in Thailand)

Sponsors & Collaborators

  • Zambart

    collaborator OTHER
  • Society for Family Health, Zambia

    collaborator UNKNOWN
  • Liverpool School of Tropical Medicine

    collaborator OTHER
  • University College, London

    collaborator OTHER
  • Population Services International

    collaborator OTHER
  • World Health Organization

    collaborator OTHER
  • UNITAID

    collaborator OTHER
  • London School of Hygiene and Tropical Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2018-02-01
Completion
2018-02-01

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02793804 on ClinicalTrials.gov